Drug intelligence / Profile preview

Yiqi Jiemin Decoction

Development stage: Unknown
Lead developer: Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
Administration: Oral

Overview

Yiqi Jiemin Decoction is a Traditional Chinese Medicine (TCM) herbal formulation developed by researchers at Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. It is primarily investigated for the treatment of moderate to severe allergic rhinitis. The decoction is designed based on the TCM principles of tonifying Qi (Yiqi) and relieving allergy (Jiemin). It aims to modulate the immune response, potentially by balancing Th1/Th2 cytokines and reducing inflammatory mediators associated with nasal hypersensitivity. Clinical trials, such as ChiCTR2200066189, evaluate its efficacy and safety compared to standard treatments like nasal corticosteroids or placebos.

Other names: Yiqi Jiemin Tang益气解敏汤

Beyond the preview

Go deeper on Yiqi Jiemin Decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yiqi Jiemin Decoction.

Explore the full profile